Key Points Healthpeak Properties pays a monthly dividend yielding 7%. The healthcare REIT's portfolio produces stable and growing income. It has a very healthy financial profile. 10 stocks we like better than Healthpeak Properties › Investing money in dividend-paying stocks is an easy way to start generating passive income. Many companies pay dividends, which gives you lots of options. One ideal option for those seeking to collect recurring passive income is Healthpeak Properties (NYSE: DOC). The real estate investment trust (REIT) recently switched to paying monthly dividends instead of the typical quarterly schedule, which better aligns the payment with your monthly expenses. It also offers a very attractive dividend yield currently above 7% (significantly higher than the S&P 500's sub-1.5% yield). A $1,000 investment would produce more than $70 of annual passive income at that rate. Here's a closer look at this top-notch income stock. Image source: Getty Images. A very healthy payout Healthpeak Properties owns a diversified portfolio of healthcare real estate. It invests in state-of-the-art lab campuses, outpatient medical buildings, and continuing care retirement communities. It focuses on owning high-quality buildings in prime locations because they benefit from growing demand. The healthcare REIT's outpatient medical building portfolio provides it withstable and growing rental income. It signs five-to-seven-year leases that feature low-single-digit annual rent bumps with high-quality healthcare systems that need space near hospitals. Meanwhile, its purpose-built lab portfolio is in high demand by biopharma companies, which drives healthy rent growth as legacy leases expire. Finally, its high-quality senior housing properties appeal to active seniors, which drives longer stays and higher occupancy. Healthpeak's portfolio works together to deliver stable and growing rental income to support the REIT's monthly dividend. It generated $1.60 per share of adjusted funds from operations (FFO) in 2024. That can easily cover its annual dividend outlay of $1.22 per share. Healthy growth Healthpeak has been growing its adjusted FFO briskly in recent years (19% over the past three years). Several factors are driving this growth. A big growth catalyst was its 2023 merger with Physicians Realty Trust. The deal created a premier owner, operator, and developer of healthcare real estate. It has been steadily capturing synergies from that transaction ($50 million last year and another $15 million expected in 2025), which have helped boost its bottom line. Story Continues Healthpeak has also benefited from rent growth across its portfolio. Last year was a record year of leasing across its outpatient medical and lab portfolio. It signed new leases at much higher rates than expiring contracts (7% on average for outpatient and 11% for lab). It was also a record year of performance by its senior housing portfolio (21% same-store net operating income growth). On top of that, the REIT is investing capital to grow its portfolio. It has spent money on several marquee lab development and redevelopment projects that have the potential to add more than $60 million to its bottom line in 2025 and beyond. It has also agreed to invest $161 million across several properties, including a preferred equity investment in a lab development project, a loan to develop a medical office building in Texas, and a loan to redevelop a lab building in California. Healthpeak also entered into a partnership with a company to develop residential housing as part of a mixed-use lab and residential area in Massachusetts. Healthpeak has ample financial flexibility to continue making new investments. The company currently has about $500 million to $1 billion in capacity to make accretive new investments or repurchase its shares. These growth drivers should enable the REIT to increase its high-yielding dividend. It recently bumped its payout up by 1.7%. A top option for passive income Healthpeak Properties' high-quality portfolio of healthcare properties produces stable and growing rental income. That supports the REIT's high-yielding monthly dividend. With built-in growth and ample investment capacity, Healthpeak should be able to increase its high-yielding payout in the future. That makes it a great option for those seeking to generate a healthy stream of passive income. Should you invest $1,000 in Healthpeak Properties right now? Before you buy stock in Healthpeak Properties, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Healthpeak Properties wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider whenNetflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation,you’d have $598,613!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation,you’d have $753,878!* Now, it’s worth notingStock Advisor’s total average return is922% — a market-crushing outperformance compared to169%for the S&P 500. Don’t miss out on the latest top 10 list, available when you joinStock Advisor. See the 10 stocks » *Stock Advisor returns as of May 12, 2025 Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool recommends Healthpeak Properties. The Motley Fool has a disclosure policy. Got $1,000 to Invest? This Healthy Monthly Dividend Stock Could Turn It Into Over $70 of Annual Passive Income. was originally published by The Motley Fool View Comments
Got $1,000 to Invest? This Healthy Monthly Dividend Stock Could Turn It Into Over $70 of Annual Passive Income.
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...